Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Olfactory Dysfunction in Seasonal Allergic Rhinitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Males and females between 18 and 59 years of age.~2. Seasonal allergic rhinitis by clinical history, with symptoms of impaired olfaction.~3. Positive skin or RAST test to allergen.~4. Symptoms of olfactory dysfunction.~5. No significant history of chronic sinusitis.~Exclusion Criteria:~1. Women of childbearing potential not using the contraception method(s) (Birth control pills, depo Provera, double barrier) as well as women who are breastfeeding.~2. Patients with severe medical condition(s) that in the view of the investigator prohibits participation in the study (heart, lung, kidney, neurological, oncologic or liver disease).~3. Use of any other investigational agent in the last 30 days.~4. Absence of olfactory or nasal symptoms.~5. Use of medications that may affect olfaction.~6. Medical conditions that may affect olfaction.~7. Smoking.~8. URI at the time of screening.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 59 Years
- Healthy Volunteers: t

Study Arms:
- Mometasone (Type: ACTIVE_COMPARATOR): Mometasone intranasal steroid therapy daily for 2 weeks
- Placebo (Type: PLACEBO_COMPARATOR): 2 puffs of placebo spray in each nostril once daily

Based on this trial design, predict the completion outcome and termination type (if applicable).